Recruiting NA INTERVENTIONAL 2-arm NCT07069647

Artificial Intelligence-Aided Screening for Patients With Diabetic Retinopathy and Age-related Macular Degeneration in Family Medicine and Geriatric Medicine Outpatient Clinics

Artificial Intelligence-Aided Screening for Patients With Diabetic Retinopathy and Age-related Macular Degeneration in Family Medicine and Geriatric Medicine Outpatient Clinics: A Randomized Controlled Clinical Trial

Sponsor: Fu Jen Catholic University Hospital

Conditions Age-Related Macular Degeneration (AMD) Diabetic Retinopathy (DR)

Interventions Standard fundus photography with physician interpretation VeriSee AI-assisted screening tools for diabetic retinopathy and age-related macular degeneration

Updated 2 times since 2025 Last updated: Nov 16, 2025 Started: Oct 2, 2025 Primary completion: Dec 31, 2027 Completion: Dec 31, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Age-Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) and is currently actively recruiting participants. Fu Jen Catholic University Hospital leads this study, which shows 2 recorded versions since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

2 versions recorded

Dec 2025 — Present [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Aug 2025 — Dec 2025 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fu Jen Catholic University Hospital
Min-Sheng General Hospital
Ministry of Health and Welfare, Taiwan
National Taiwan University Hospital

Data source: National Taiwan University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taipei, Taiwan